Identification of Medicinal Products (IDMP) Standards Part 2: The Implementation Roadmap

Posted 28 February 2017 By Dieter Schlaps

placeholder+image This is part two of a series on the Identification of Medicinal Products (IDMP) standards and their respective implementation guidelines. Part two reports on current IDMP activities and provides the plans and timelines in the IDMP implementation process. Part one presented the reasons for the new standard, the driving forces behind IDMP and the concepts behind the standard.

Share this article:

Categories: Biologics and biotechnology, Drugs, Features, US, Europe, FDA, EMA

Tags: ISO, ISO IDMP, Identification of Medicinal Products

Regulatory Exchange: Latest Updates From the Community